2025-10-19 - Analysis Report
Okay, here's an analysis of Lam Research (LRCX) based on the provided data. I'll follow the requested format.

## LRCX Stock Analysis (October 20, 2025)

**0) Overview**

This report analyzes Lam Research Corp. (LRCX), a key player in the semiconductor equipment industry, focusing on its stock performance, financial health, and market sentiment. We'll cover historical returns, technical indicators, analyst opinions, recent news, and financial data to provide a comprehensive overview.

**1) Performance vs. S&P 500 (VOO)**

*   **Ticker:** LRCX
*   **Company:** Lam Research Corp.
*   **Description:** Lam Research is a global supplier of wafer fabrication equipment and services to the semiconductor industry.
*   **LRCX Cumulative Return:** 236.68%
*   **VOO Cumulative Return:** 97.05%
*   **Spread (vs. VOO):**
    *   Max: 155.3
    *   Min: -15.5
    *   Current: 132.4
    *   Relative Spread: 86.6

**Analysis:** LRCX has significantly outperformed the S&P 500 (VOO) over the analyzed period. The current spread of 132.4, with a relative spread of 86.6, suggests that LRCX is trading near the higher end of its historical outperformance range.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
|------------|---------|---------|---------|-------|--------|
| 2015-2017  | 84.0%   | 67.8%   | 56.0%   | 0.0   | 23.2   |
| 2016-2018  | 18.0%   | 68.1%   | 3.0%    | 0.1   | 17.2   |
| 2017-2019  | 53.0%   | 82.9%   | 31.0%   | 1.2   | 36.9   |
| 2018-2020  | 66.0%   | 82.9%   | 42.0%   | 1.1   | 59.5   |
| 2019-2021  | 119.0%  | 82.9%   | 73.0%   | 1.0   | 90.7   |
| 2020-2022  | -10.0%  | 79.2%   | -9.0%   | 0.9   | 53.0   |
| 2021-2023  | -13.0%  | 80.4%   | -15.0%  | 1.0   | 98.8   |
| 2022-2024  | -52.0%  | 80.4%   | -72.0%  | 1.0   | 91.1   |
| 2023-2025  | 148.0%  | 80.4%   | 86.0%   | 0.9   | 178.4  |

**Analysis:**

*   **CAGR:** The Compounded Annual Growth Rate shows a wide range of performance, from substantial growth periods (e.g., 148.0% in 2023-2025) to periods of decline (e.g., -52.0% in 2022-2024).
*   **MDD:** High Maximum Drawdown figures indicate significant volatility and risk.
*   **Alpha:** Positive alpha values suggest that LRCX has outperformed its benchmark, while negative values indicate underperformance.
*   **Beta:** A beta around 1 suggests that LRCX's volatility is similar to the market.
*   **Cap(B):** The market capitalization has generally increased over time, reflecting overall growth, but also considerable drawdown during 2020-2022, 2021-2023, 2022-2024.

**2) Recent Price Action**

*   **Current Price:** 141.51
*   **Last Market Data:** {'price': 141.51, 'previousClose': 142.405, 'change': -0.63}
*   **5-day Moving Average:** 140.956
*   **20-day Moving Average:** 137.5525
*   **60-day Moving Average:** 115.3647

**Analysis:** The stock price has decreased slightly from the previous close. The 5-day moving average is above the 20-day moving average, and both are significantly above the 60-day moving average, suggesting an upward trend, although recent momentum might be slowing down.

**3) Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.5 (Low Investment)
*   **RSI:** 58.79
*   **PPO:** -0.83
*   **Hybrid Signal:** cash_80%_Sell 80.0% of holdings (2491 shares - Risky - MRI:0.50) (Cash Ratio: 80% on 2025-10-16)
*   **Delta_Previous_Relative_Divergence (20-day):** -1.6 (Negative - short-term decline)
*   **Expected Return:** 19.7% (Long-term, vs. S&P 500)

**Analysis:**

*   **MRI:** Indicates low investment recommendation, suggesting that the current risk level is moderate.
*   **RSI:** At 58.79, RSI is nearing overbought territory but not there yet, suggesting upward momentum.
*   **PPO:** A slightly negative PPO indicates that the short-term moving average is slightly below the long-term moving average, implying a possible weakening trend.
*   **Hybrid Signal:** The signal recommends selling 80% of holdings and holding a high cash position, signaling caution.
*   **Delta_Previous_Relative_Divergence:** A negative value indicates short-term underperformance relative to its historical trend.
*   **Expected Return:** A 19.7% expected return over the long term is positive, suggesting confidence in future outperformance.
*   **Recent Price Change:** The slight decrease from the previous close reflects minor volatility, but it doesn't represent a significant downward trend on its own.

**4) Recent News & Significant Events**

*   **[2025-10-18] Is Lam Researchâ€™s Rally Justified After AI Chip Surge and Strong 2025 Momentum? (Simply Wall St.):**  This suggests that the stock's recent gains are being evaluated in light of industry trends (AI chips) and its own performance.
*   **[2025-10-17] Tesla Stock Holds Near Highs Ahead Of Q3 Results; Netflix, Intel, IBM Also Due (Investor's Business Daily):** Mentions other tech companies but doesn't directly impact LRCX analysis.
*   **[2025-10-17] 1 Tech Stock to Buy Before the End of 2025 (Motley Fool):** This indicates positive sentiment towards LRCX and its potential for further growth.
*   **[2025-10-17] The Zacks Analyst Blog Highlights NVIDIA, Roche, Lam Research, Tredegar and Kewaunee Scientific (Zacks):**  Positive highlight suggests analyst recognition and favorable view.
*   **[2025-10-16] Lam Research (LRCX) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks):**  Contrasts with some other news, indicating recent underperformance compared to the market.

**Analysis:** The news is mixed. While some articles highlight the company's strong momentum and potential, others point to recent underperformance relative to the broader market.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean: 1.74)
*   **Target Price:**
    *   Average: 128.49
    *   High: 175.00
    *   Low: 80.00
*   **Recent Rating Changes:** Not specified.

**Analysis:**  Analyst consensus is generally positive ("Buy"). However, the average target price (128.49) is *below* the current price (141.51), suggesting that analysts may believe the stock is currently overvalued or that future growth is already priced in.  The wide range between high and low target prices indicates uncertainty.

**5) Recent Earnings Analysis**

| Date       | EPS   | Revenue |
|------------|-------|---------|
| 2025-04-25 | 1.04  | 4.72 B$ |
| 2025-01-31 | 0.93  | 4.38 B$ |
| 2024-10-28 | 0.86  | 4.17 B$ |
| 2024-01-29 | 7.25  | 3.76 B$ |
| 2025-01-31 | 0.72  | 3.76 B$ |

**Analysis:**
*   EPS and Revenue has generally increased but data has repetition(2025-01-31) for duplicate dates, which seems strange. The data appears to have inconsistency. More recent dates should show more data to show recent revenue growth.

**6) Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-06-30 | $5.17B    | 50.08%        |
| 2025-03-31 | $4.72B    | 49.02%        |
| 2024-12-31 | $4.38B    | 47.37%        |
| 2024-09-30 | $4.17B    | 48.05%        |
| 2024-06-30 | $3.87B    | 47.53%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE    |
|------------|-----------|--------|
| 2025-06-30 | $9.86B    | 17.44% |
| 2025-03-31 | $9.51B    | 13.99% |
| 2024-12-31 | $8.81B    | 13.52% |
| 2024-09-30 | $8.47B    | 13.18% |
| 2024-06-30 | $8.54B    | 11.95% |

**Analysis:**

*   **Revenue:** Shows a clear upward trend over the past five quarters.
*   **Profit Margin:** Profit margins are consistently high and increasing, which is positive.
*   **Equity:** Increasing equity also shows healthy growth.
*   **ROE:** Return on Equity has been increasing indicating improved profitability.

**7) Overall Summary**

LRCX has demonstrated strong historical outperformance compared to the S&P 500. Recent financial data indicates healthy revenue growth, high profit margins, and increasing equity and ROE.  However, several factors suggest caution:

*   **Technical Indicators:** The Hybrid Signal recommends a high cash position, and the Delta_Previous_Relative_Divergence indicates short-term underperformance.
*   **Analyst Opinions:** While the consensus is "Buy," the average target price is below the current price, implying potential overvaluation.
*   **News:** Recent news is mixed, with some articles highlighting strengths while others point to recent underperformance.
*   **MRI** with 0.5 shows the investment is Low, more safer side.

**Conclusion:**

LRCX is a fundamentally strong company in a growing sector (semiconductors, AI chips).  However, the current market conditions and technical indicators suggest that the stock might be fully valued or even overvalued in the short term. The Hybrid Signal recommends selling 80% of existing shares. A balanced approach, considering both the long-term potential and the short-term risks, is advised. Investors should carefully consider their risk tolerance and investment horizon before making any decisions.
